Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DRUG compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
DRUG
Bright Minds Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
DRUG
Bright Minds Biosciences Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
DRUG
Bright Minds Biosciences Inc.
Change
20.40
▲
+7.59%
· post 20.76
· delayed
Mkt cap
$144.8M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,362.81
· delayed
After hours
Nov 5 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 5 '26
delayed
DRUG
Bright Minds Biosciences Inc.
vs
LLY
ELI Lilly & Co
20.40
▲
+7.59%
post 20.76
delayed
Price
1,371.32
▼
−3.29%
post 1,362.81
delayed
$144.8M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
DRUG
20.40
▲
+7.59%
vs
LLY
1,371.32
▼
−3.29%
After hours
Nov 5 '26
delayed
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
DRUG, solid
LLY, dashed